Results 141 to 150 of about 89,230 (317)

Lymph Protein in Hepatic Cirrhosis and Experimental Hepatic and Portal Venous Hypertension

, 1968
Charles L. Witte, Marlys H. Witte, ALLAN E. DOMONT, JOHN FRIST, William R. Cole   +4 more
openalex   +2 more sources

The Lymphatic Drainage in Portal Hypertension [PDF]

, 1969
R Mégevand
openalex   +1 more source

Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit

United European Gastroenterology Journal, EarlyView.
ABSTRACT Introduction Management of hepatic encephalopathy relies on the identification and control of precipitating factors (PF). The prognostic value of a PF is unknown, which we aimed to explore. Patients and Methods Single‐center retrospective study of cirrhotic patients included in a prospective cohort admitted to an intensive care unit (ICU ...
Marika Rudler, Marie de Matharel, Charlotte Bouzbib, Sarah Mouri, Lyes Kheloufi, Nicolas Weiss, Philippe Sultanik, Dominique Thabut   +7 more
wiley   +1 more source

Portal Hypertension Secondary to Pancreatic Disease *

, 1960
William V. McDicrmott
openalex   +2 more sources

CiThroModel Improves Prediction of Symptomatic Venous Thromboembolism in Hospitalized Patients With Cirrhosis Without Hepatocellular Carcinoma

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background & Aims Venous thromboembolism (VTE) is a recognized complication of acutely ill patients, but its incidence and risk factors in those with cirrhosis are uncertain. Methods We retrospectively studied a consecutive cohort of cirrhosis patients non‐electively admitted to our medical unit to determine the rates of symptomatic VTE during
Alberto Zanetto, Alessandro Vitale, Filippo Pelizzaro, Vittorio Simeon, Elena Campello, Laura Turco, Lorenz Balcar, Francesco Paolo Russo, Patrizia Burra, Paolo Simioni, Marco Senzolo   +10 more
wiley   +1 more source

A Computer Based Index for the Prediction of Operative Survival in Patients with Cirrhosis and Portal Hypertension

, 1969
John H. Siegel, James B. Williams
openalex   +2 more sources

Idiopathic noncirrhotic portal hypertension: current perspectives

Hepatic Medicine: Evidence and Research, 2016
Oliviero Riggio,1 Stefania Gioia,1 Ilaria Pentassuglio,1 Valeria Nicoletti,1 Michele Valente,2 Giulia d’Amati2 1Department of Clinical Medicine, Center for the Diagnosis and Treatment of Portal Hypertension, 2Department of Radiological, Oncological,
Riggio O, Gioia S, Pentassuglio I, Nicoletti V, Valente M, d’Amati G   +5 more
doaj  

Rifaximin‐α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background and Aims Hepatic encephalopathy is a frequent complication of cirrhosis. Rifaximin‐α has been included in guidelines for secondary prevention of hepatic encephalopathy, but there are few real‐world data on its efficacy and impact on healthcare utilization.
Diederick J. van Doorn, Kirsi. M. A. van Eekhout, Koos de Wit, L. C. Baak, Michael Klemt‐Kropp, Bart J. Verwer, Philip Friederich, Gijs J. de Bruin, Xander G. Vos, Joost P. H. Drenth, R. Bart Takkenberg   +10 more
wiley   +1 more source

MEASUREMENT OF BLOOD FLOW THROUGH PORTOPULMONARY ANASTOMOSIS IN PORTAL HYPERTENSION

, 1965
Teizo Tazawa
openalex   +2 more sources

Postoperative TIPS Reaction in a Patient With Portal Vein Dysfunction

Portal Hypertension &Cirrhosis, EarlyView.
Qihao Du, Jiaming Lan, Ke Xu, Meng Niu
wiley   +1 more source